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Abstract
Purpose Recurrent miscarriage (RM) is a stressful con-
dition which gives rise to extensive diagnostic evaluation
and is seen as a potentially curable maternal disease.
Nevertheless, epidemiological data have shown that out-
come is related to fertility. In addition to maternal age and
number of preceding miscarriages, further markers derived
from the past history may support counselling.
Methods Observational trial comprising 228 couples who
were referred between 1996 and 2003 for immunological
evaluation at maternal ages 20–39 years after three or more
spontaneously conceived primary first trimester miscar-
riages. They were interviewed in 2005, ongoing pregnan-
cies were followed up until birth in 2006. Past obstetric
history was correlated with 2 year cumulative pregnancy
and delivery rates (CPR, CDR).
Results CPR and CDR were 206/228 (90.4 %) and
174/228 (76.4 %). Duration of infertility was associated
with lower CPR (up to 3/[3 years, p\ 0.01), whereas age
and number of preceding losses inversely correlated with
CDR (\35 years/35–39 years, p\ 0.002; 3/[3 miscar-
riages, p\ 0.002). Detection of an embryonic heart beat in
2–3 of the first three miscarriages resulted in favourable
outcome (CPR: p\ 0.02, CDR: p\ 0.002). Prognosis was
excellent in younger fertile women after three miscarriages
where vital signs had been detected; under less favourable
conditions not only risks for further miscarriage, but also
for secondary infertility were elevated.
Conclusion Secondary infertility is a feature of RM.
Embryonic vital signs in preceding pregnancies are prog-
nostic markers and should be regarded as a strong con-
founding factor in trials on therapeutic interventions.
Prevention may be more appropriate than treatment.
Keywords Spontaneous abortion  Pregnancy loss 
Embryo  Cardiac activity  Infertility  Karyotype
Introduction
About 12–15 % of clinical pregnancies end in spontaneous
abortion, and an estimated 1 % of women who desire
children suffer from recurrent miscarriages. According to
the WHO, this term is defined as consecutive loss of three
or more pregnancies up to the 20th gestational week [1],
and 90 % occur in first trimester [2]. International guide-
lines of the gynaecological societies adopted the WHO
definition, and from the knowledge that about 50 % of
losses are caused by cytogenetic abnormalities while 50 %
are chromosomally normal, they followed the concept that
euploid losses indicate a maternal and potentially curable
disease.
Although embryonic factors which lead to aneuploidy
are the only clearly defined cause of miscarriage, karyotypic
evaluation of the abortus has not become a routine
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procedure due to technical and financial reasons. Therefore,
the guidelines concentrate on evaluation of associated
maternal factors deducing therapeutic options [3–5]. Nev-
ertheless, about 25–50 % of cases remain unexplained
according to this model [5, 6], and cure rates have been
stable for the past 60 years ranging from 55 to 85 % [7–10].
In parallel, epidemiological evidence has shown that
the prospects after recurrent miscarriages can be excel-
lent. Moreover, factors derived from the obstetric his-
tory, e.g., maternal age and number of preceding
miscarriages, independently have a negative impact on
the prognosis [8, 11, 12]. Miscarriages have also been
linked to subfertility [13].
In an observational follow-up study, we intended to get
a basis for counselling couples on their prospects within the
near future. Basic information derived from the past history
was correlated not only with the chance to conceive a child
but also to get pregnant at all. We concentrated on a group
of women below 40 years with primary miscarriages who
had conceived spontaneously. Morphological examination
by ultrasound has revealed that in sporadic pregnancies, the
establishment of cardiac activity is an important milestone
of embryonic organogenesis. The chance of a pregnancy to
develop normally is markedly higher after embryonic vital
sign have been detected. For women below 35–40 years,
the figures rise from 75 to 90–95 % [14–16]. Since this
parameter is routinely examined in early pregnancy as a
part of prenatal care, we evaluated whether it is also
prognostically relevant in case of pregnancy loss.
We did not analyse the possible effect of secondary
treatments, e.g., lymphocyte immunotherapy, ASS or low
molecular weight heparin because we did not expect them to
‘‘override’’ biological factors which are derived from the
obstetric history and which are related to the capacity of the
early embryo to develop. The results may contribute to an




After three or more miscarriages, couples are referred to
our tertiary immunological practice by gynaecologic
practitioners, geneticists, and reproductive medical centres
in Germany. Lymphocyte immunotherapy (LIT) is con-
sidered as an optional treatment in selected cases of pri-
mary idiopathic recurrent miscarriages as defined by the
gynaecological guidelines. The method has been intro-
duced in our centre in the 1980s and is approved by the
local health authority. The criteria for recommending LIT
have been outlined elsewhere. Surveillance after LIT
showed very low or undetectable risks for the woman
treated and the children born subsequently [17, 18].
Study design
Observational study on 336 couples who were consecu-
tively referred between 1996 and 2003 and fulfilled the
following criteria: three or more miscarriages from the 5th
to 15th gestational week after spontaneous conception,
female age below 40 years, no deliveries, no late miscar-
riages, no pregnancy in a preceding partnership. The
diagnostic work-up by the referring practitioners partly
adhered to the contemporary guidelines for diagnosis and
treatment and comprised pelvic ultrasound (all cases), TSH
(all cases), hysteroscopy (103 women, 45.2 %), cytoge-
netic evaluation of both partners (195 couples, 85.5 %
revealing normal results), haemostaseologic evaluation
(complete numbers tested uncertain), and details concern-
ing the past miscarriages (gestational age, detection of
embryonic vital signs, embryonic aneuploidy were tested).
Fifty-eight (25.4 %) women were tested for autoantibodies
and antiphospholipid syndrome. Missing or abnormal
diagnostic results did not lead to exclusion from the study
[19].
In 2005, they were contacted a second time. Of 228
eligible couples (67.9 %), 144 returned the questionnaire,
222 were contacted by telephone, and in 30 cases addi-
tional information was given by the practitioners with the
patients’ consent. Time of observation was 24–108 months
after initial immunological evaluation (n = 114) and after
LIT (n = 114), respectively. Pregnancies were followed up
until delivery in 2006. Within a 24 month period, mean
outcome measures were the cumulative pregnancy and
birth rate, meaning the rate of conceptions leading to first
delivery.
In the cohort, 114 (50 %) had received LIT, the others
had no met the LIT criteria (e.g., other causes for recurrent
miscarriages detected, no cytogenetic workup, HLA anti-
bodies present, partner not suited for cell donation
according to the guidelines of donor selection in transfu-
sion medicine).
Of 336 couples, 84 (25 %) were lost to follow up, and
24 (7.1 %) turned out not to fulfil the criteria of the trial
(n = 11) or had stopped trying to achieve pregnancy
(n = 13). The loss of follow up rate was higher in couples
who had their initial evaluation before 1999 and who did
not undergo LIT. It is partly explained by loss of the cur-
rent addresses. The concept of the study was approved by
the ethics committee of the medical faculty of Kiel
University and by the local data protection official.
1114 Arch Gynecol Obstet (2016) 293:1113–1123
123
Definition of gestational age
In Germany, prenatal care of gynaecological practitioners
includes an ultrasound scan in gestational weeks 8?0 to
11?6 in order to detect gross malformations and to define
the prospective date of delivery. Moreover, ultrasound
scans are widely used to detect an intact intrauterine
pregnancy in the 6th–8th gestational week. Gestational age
in very early pregnancy is defined as weeks after the last
menstrual period, from the 7th week on it is based on the
ultrasound findings. The embryonic phase of development
is completed in the 10th week, and developmental arrest in
this phase becomes apparent until the 12th week.
Statistics
Study data are described by proportions and rates as well as
by mean and median values (ranges, standard deviations)
for quantitative variables. Stepwise multiple logistic
regression analysis was used to assess the influence of
selected factors from the past obstetric history on CPR and
CDR. In this exploratory study a p value\0.05 was con-
sidered significant. The effect of selected markers was
evaluated by odds ratios incl. 95 % confidence limits.
Results
Study group
A group of 228 couples underwent initial immunological
evaluation (IE) in 1996–2003 after at least three first trime-
ster miscarriages and gave sufficient information in 2005. At
IE the women were 32 years old (median, 21–39 years) and
had 3 miscarriages (median, range 3–7) within a waiting time
of 3 (0–16) years: 171 women (75.0 %) had three, 43
(18.9 %) four, 11 (4.8 %) five, 2 (0.9 %) six, and 1 couple
(0.4 %) had 7 miscarriages. Mean gestational age at time of
miscarriages was 8.4 ± 1.1 weeks (5–15 weeks), in 431 of
759 miscarriages (56.8 %) the embryonic heart beat was
detected from the 7th week on, with close similarity in all
maternal age groups (Table 1; Fig. 1).
Within 24 months after IE, 206 woman achieved preg-
nancy (90.4 %), and 22 (9.6 %) developed secondary
infertility. 174 women (76.4 %) conceived their first child,
10 of them their second one. Thirty-four of 228 (14.9 %)
commenced infertility treatment using allogeneic insemi-
nation with the husband’s sperm (AIH) or in vitro fertilisa-
tion (IVF). Women under 30 years reported on this most
frequently (12/66, 18.2 %). With infertility treatment, 12 of
34 women were delivered, and 4 finally conceived sponta-
neously. Of 12 pregnancies conceived after treatment, five
ended prematurely, and three of these very prematurely.
Evaluation of associated pathologies of recurrent
miscarriages
Andrological impairment of variable extent was found in
26 of 141 partners, and 80 (35.1 %) of the female patients
reported on abnormal findings: tubal incompetence (ex-
trauterine pregnancy 96, unilaterial salpingectomy 94,
adhesions 93), uterine (myoma 94, septate uterus 95,
polyp 91, conisation for cervical dysplasia 94),
endometriosis (n = 5), thyroid disease (Hashimoto thy-
roiditis, struma, n = 11), endocrine (corpus luteum
incompetence, polycystic ovary syndrome, hyperandroge-
naemia, hyperprolactinaemia, n = 28), factor V Leiden
mutation (n = 9). Cytogenetic aneuploidy of the embryo
was found in 16 women.
Cumulative pregnancy and delivery rates
within 24 months
Dichotome variables derived from the past obstetric his-
tory were related to the cumulative pregnancy and
delivery rates: female age (20–34 years/35–39 years),
partner’s age (20–34 years/[34 years), number of mis-
carriages (3/[3), duration of infertility (1–3/[3 years),
and embryonic vital signs in the first three miscarriages
(0–1/2–3). While the age of the male partner did not have
a significant impact, the pregnancy rate was significantly
higher when the waiting time was less than 3 years, when
vital signs had been present in most of the first three
miscarriages, and there was a trend concerning the num-
ber of preceding miscarriages. The conception rate was
higher in younger women (below 35 years), with low
numbers of miscarriages and detection of embryonic vital
signs (Table 2).
The main group of 132 women below 35 years had an
overall chance of 85 % to conceive their first child after
three miscarriages, and the rate was nearly 100 %, when
embryonic vital signs had been present before. Under least
favourable conditions the pregnancy rate dropped to 70 %
and the delivery rate to 40 % (Fig. 2a, b; Table 3).
Possible factors indicating reduced fertility (reduced
sperm count, tubal pathology, preceding extrauterine
pregnancies, and uterine abnormalities, 47 couples) were
not significantly associated with the outcome at univariate
analysis (data not shown).
Deliveries after recurrent miscarriages
Of 174 women conceiving their first child, 170 had sin-
gleton pregnancies (89 girls, 81 boys) and 4 had multiples
following infertility treatment: three pairs of twins (3 girls,
3 boys), and one triplet with only one boy developing to
term.
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Table 1 Past obstetric history and outcome after immunological evaluation (IE)
Female age at IE 21–29 years 30–34 years 35–39 years Total
No.of couples 66 106 56 228
Median duration of infertility
(years, range)
2 (0–7) 3 (0–7) 3.5 (0–16) 3 (0–16)
Miscarriages before IE:
Three 52 (78.8 %) 80 (75.5 %) 39 (69.6 %) 171 (75.0 %)
Four 12 (18.2 %) 18 (17.0 %) 13 (23.2 %) 43 (18.9 %)
5–7 2 (3.0 %) 8 (7.5 %) 4 (7.1 %) 14 (6.1 %)
Total no. of pregnancies 216 357 193 766
Of these extrauterine 0 5 2 7
Of these intrauterine 216 352 191 759
Median no. per couples (range) 3 (3–7) 3 (3–5) 3 (3–6) 3 (3–7)
Vital signs present 125 (57.8 %) 192 (54.5 %) 109 (57.1 %) 426 (55.6 %)
Biochemical/preclinical (4th–5th week) 18 (8.3 %) 33 (9.4 %) 11 (5.8 %) 62 (8.2 %)
Embryonic phase (6th–12th week) 192 (88.9 %) 312 (88.6 %) 173 (90.6 %) 677 (89.2 %)
Early foetal phase (13th–15th week) 7 (3.2 %) 7 (2.0 %) 5 (2.6 %) 19 (2.5 %)
Mean interpregnancy interval
(months, range)
9.3 ± 3.5 (4–30) 9.1 ± 3.6 (2.5–30) 10.9 ± 4.7 (3.5–33.5) 9.8 ± 3.9 (2.5–33.5)
Outcome 2 years after IE
Couples with further pregnancies 60 (90.9 %) 100 (94.3 %)
(of these 1 extrauterine)
46 (82.1 %) 206 (90.4 %)
Of these:
Conception of first child 51 (77.3 %) 90 (84.9 %) 33 (58.9 %) 174 (76.4 %)
Miscarriages only 9 (13.6 %) 10 (9.4 %) (of these
1 extrauterine)
13 (23.2 %) 32 (14.0 %)
Couples with secondary infertility 6 (9.1 %) 6 (5.7 %) 10 (17.9 %) 22 (9.6 %)
Total no. of pregnancies 78 128 55 261
Pregnancies per couple (range) 1.18 (0–3) 1.21 (0–3) 0.98 (0–2) 1.14 (0–3)
Male factor infertility 8 (12.1 %) 8 (7.5 %) 10 (17.9 %) 26 (11.4 %)



























Fig. 1 Miscarriages reported
before immunological
evaluation (n = 757, 228
couples)
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The rate of premature deliveries (24th to completed 37th
gestational week) was 16.7 % (29/174), and the rate of
very premature deliveries was 2.9 % (5/174, 24th to 31st
week). In 83 cases (47.7 %), complications of pregnancy
were reported, the most frequent being vaginal bleeding in
the first trimester (n = 45, Table 4). Two very premature
infants succumbed pre- and one postnatally (3 of 177
infants, 1.7 %). Eleven of 174 living infants (6.3 %) had
major malformations or handicaps. These comprised tri-
somy 21, cardiac anomaly, Jeune’s syndrome, spinal
muscular atrophy, unilateral renal agenesis, hypospadia,
connatal deafness, and neuromuscular retardation (n = 4).
The rate of these impairments was 3 of 51 (6 %) in women
aged 21–29 years, 3 of 90 (3 %) in women aged
30–34 years, and remarkably high (5 of 33, 15 %) in those
aged 35–39 years, as compared to the younger women
(p = 0.02). One of these 5 children was born after embryo
transfer to a mother aged 37 years, the others were con-
ceived spontaneously.
Discussion
Our data illustrate that after three early miscarriages the
chance to conceive the first child within 2 years is good or
excellent for younger women who have achieved their first
pregnancies spontaneously. They also confirm current
knowledge that the chances decrease with the number of
miscarriages as well as with female age because of a higher
risk of further miscarriage. As we could show here, sec-
ondary sterility accounts for the decrease as well and
therefore is a characteristic feature of recurrent
miscarriages.
Additionally, our data provide evidence that vital signs
found in preceding pregnancies can serve as a non-invasive
prognostic marker in recurrent miscarriages. When the
preceding embryos have reached a higher developmental
age, the chances to get pregnant as well as to conceive
successfully are significantly higher than after repeated
early disruption. We conclude that sporadic and even more
so recurrent early miscarriages do not simply occur acci-
dentally, but reflect the intrinsic fertility of a woman. The
role of her partner is difficult to define to date. At least will
reduced male fertility account for longer waiting times
between pregnancies.
As a technique requiring an invasive procedure, cyto-
genetic evaluation of the conceptus obtained by uterine
evacuation or by chorionic villi sampling has been estab-
lished since the 1960s and late 1980s, respectively.
Depending on gestational and female age, about 50–80 %
of early miscarriages are caused by aneuploidy of the
embryo or—much less frequently proven—to mosaicism
which may be confined to the placenta only [20–22]. The
patterns of aneuploidy differ with maternal and gestational
ages, and the type of aneuploidy roughly determines the
developmental age the conceptus is able to reach. Thus,
nonviable trisomies 16 or 22 can present as anembryonic
structures or proceed to cardiac activity [23, 24]. As has
Table 2 Multivariate logistic regression on prognostic factors and cumulative pregnancy and delivery rates 2 years after immunological

























35–39 years 46/56 (82.1 %) 34/56 (60.7 %)
Age of male
partner at IE







[34 years 76/67 (87.4 %) 59/67 (67.8 %)
Duration of
infertility





[3 years 62/75 (82.7 %) 51/75 (68.0 %)
No. of preceding
miscarriages





[3 47/57 (82.5 %) 34/57 (59.6 %)
Embryonic heart
beat in the first 3
pregnancies
detected
0–1 88/103 (85.4 %) 3.35 0.016 1.26–8.92 67/103 (65.0 %) 3.25 0.001 1.64–6.43
2–3 118/125 (94.4 %) 108/125
(86.4 %)
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been shown in detail for monosomy X, the whole spectrum
from a ‘‘blighted ovum’’ to delivery of a viable child may
be possible [25]. While monosomic embryos are usually
unable to implant, not only monosomy X, but also tri-
ploidy, and certain trisomies (e.g., trisomies 13, 18, 21,
triple X, XXY) allow for organogenesis and even viability.
At the same time, these trisomies are more prevalent in
elder women. Nevertheless, the conclusion that vital signs
are more often detected in elder women cannot be drawn
from our collective (Table 1).
From the geneticist´s point of view, the developmental
stage which can be reached in aneuploidy is explained by
the degree of genetic imbalance caused by extra or missing
chromosomes. Nevertheless, it is unclear which factors
actually lead to developmental arrest. Structural abnor-
malities do not only occur in aneuploid, but also in
chromosomally normal embryos [26, 27]. After missed
abortion, Phillip found that only 7 % had a normal kary-
otype and were morphologically intact [28]. This has been
attributed to monogenic lethal factors [29]. There may be
additional factors originating from the maturation of the
oocyte and the constitution of the embryo which influence
its capacity to develop; e.g., at early cleavage stages, the
embryo apparently is able to overcome mosaicism [21].
These factors may explain why vital signs in first trimester
pregnancy indicate a favourable prognosis although it may
be aneuploid.
An additional impact of environmental factors on early
embryonic development and nidation, e.g., the tubal and
endometrial milieu cannot be excluded, and tubal impair-
ment, uterine malformations, septum, or submucous
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Fig. 2 a Cumulative pregnancy
and delivery rates after three
early miscarriages, dependant
on female age (n = 171).
b Cumulative delivery rates
after three early miscarriages,
dependant on female age and
detection rate of vital signs in
preceding miscarriages
(n = 171)
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are frequently observed, and their role in recurrent mis-
carriages is discussed controversially to date [3, 4, 30].
Moreover, together with andrological subfertility they can
contribute to secondary sterility. In our collective, required
diagnostic evaluation and infertility treatment may have
delayed pregnancy in some couples within 24 months of
observation. Remarkably though, after exclusion of all 47
couples who had reported on andrological, tubal, or uterine
impairment, success rates of 181 remaining couples were
merely unchanged (see Table 3).
Our results lead to the conclusion that the chance to
detect vital signs decrease with higher grade recurrent
miscarriages due to selection. This has also been
observed but to our knowledge has not been studied
specifically by other authors [11, 31]. In order to avoid a
bias, we chose to weigh only the first three miscarriages.
Further studies are necessary to rule out whether the
marker is equally valid in higher grade recurrent mis-
carriages or in women age 40 years and older. Never-
theless, it has a strong impact in women under 40 years
of age and should be regarded as a strong confounding
factor whenever diagnostic or therapeutic measures for
couples suffering from recurrent miscarriages are eval-
uated. We speculate that in a population with miscar-
riages following fertility treatment, the chance to detect
vital signs will be lower. Therefore it may be relevant to
describe whether a study population comprises couples
requiring fertility treatment.
By interviewing the patients closely, we obtained
detailed clinical information on past history and further
outcome. Although the evaluation has been done in 2005
and refers to a collective who had been seen with recurrent
miscarriages as far as 9 years earlier, we think that the
results are still valid because all women had conceived
spontaneously. Since the loss of follow-up rate (25 %) is
attributed to loss of current addresses we presume that the
results are not markedly distorted. They are plausible when
compared to other studies (as below, Table 4).
Concerning diagnostic results, the mode of obtaining
data by reports of the referring practitioners and the
patients may be a weakness of our study. The ultrasound
and gynaecological evaluation were performed by the
referring practitioners and not subject to standardised study
criteria. In case of missed abortion the developmental age
of the embryo had not been defined. We cannot exclude

































1 No No No 7 5 71.4 3 42.9
2 No No Yes 10 7 70.0 4 40.0
3 No Yes No 17 15 88.2 9 52.9
4 Yes No No 21 17 81.0 13 61.9
5 No Yes Yes 22 19 83.4 17 77.3
6 Yes No Yes 19 18 94.7 14 73.7
7 Yes Yes No 58 51 87.9 43 74.1
8 Yes Yes Yes 74 74 100 71 95.9
The categories are based on the odd’s ratios (Table 2) of the defined criteria which are significantly correlated with the observed outcome. When
47 couples are excluded because of reported sterility factors (tubal incompetence, uterine disorders, andrological), figures do not change
significantly: 168/181 couples (92.8 %) achieved pregnancy (p = 0.38), 145/181 couples (80.1 %) were delivered (p = 0.38). CPR: 75 %/
66.7 %/88.9 %/88.2 %/83.3 %/94.4 %/95.1 %/100 % in the six categories, CDR: 25 %/44.4 %/55.6 %/70.6 %/77.8 %/72.2 %/80.5 %/96.9 %
Table 4 Prenatal complications (83 of 174 women, 47.4 %)
Complication No. of women (%)
First trimester bleeding 45 (25.9)
Placenta praevia 1 (0.6)
Premature placental abruption 2 (1.1)
Placenta accreta 3 (1.7)
Perinatal demise 3 (1.7)
Pre-eclampsia, hypertension 7 (4.0)
Gestational diabetes 10 (5.7)
Acute or chronic placental incompetence,
intrauterine retardation
9 (5.2)
Cervical incompetence 8 (4.6)
Premature rupture of membranes (ROM) 4 (2.3)
Premature labour 6 (3.4)
Pyelonephritis 1 (0.6)
Infection (amnion, cervix) 8 (4.6)
Pulmonary embolism 1 (0.6)
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that in some 7th week losses where no heart beat has been
reported, ultrasound had not actually taken place. Never-
theless, information on this aspect has been obtained at
least twice (at immunological evaluation, at LIT, and
finally by means of a questionnaire), and seems plausible
(Fig. 1).
Our collective does not represent a group of idiopathic
recurrent miscarriages in its classical sense as women have
not been excluded on the basis of pathological or missing
genetic, gynaecologic or laboratory results. At present
knowledge, an inherited heterozygous mutation of coagu-
lation factors (e.g., factor V Leiden) or detection of
antiphospholipid antibodies are not clinically relevant in first
trimester abortions but rather may underlie pathologies in
the second or third trimester [32–35]. Therefore, lack of the
respective laboratory results is not regarded as a confound-
ing factor. Nearly 15 % of the couples have not been eval-
uated cytogenetically. Since the detection rate after recurrent
early loss is about 2–5 % [4], this factor is considered
negligible in our cohort. It would have been valuable to
stratify for hormonal impairment like polycystic ovary
syndrome, female body mass index, or life style factors such
as nicotine and alcohol consumption, but these aspects were
not included at the primary assessment of the data.
In our evaluation, unexpectedly a significant impact of
female age on the cumulative pregnancy rate could not be
shown. Two reasons may have contributed: women in their
40s were not included, and women aged 30–34 years
possibly decided more easily for another pregnancy than
younger women. Moreover, a higher proportion of the
young couples apparently had underlying fertility prob-
lems. Male factor infertility and finally infertility treatment
were more prevalent (Table 1). This may also explain why
cumulative delivery rates do not differ between women
below 30 years and 30–34 years in our cohort.
Comparison of observational trials on recurrent
miscarriages (Table 5)
The association of maternal age and number of preceding
miscarriages with further outcome has been addressed in
several reviews [8, 9, 36] and recent studies [10, 11, 37,
38]. Since inclusion and exclusion criteria and study
designs differ, close comparison of the results is not pos-
sible. Nevertheless, evidently our cohort represents a rel-
atively fertile group of women: it comprises women below
40 years of age, and couples who had already undergone
in vitro fertilisation or insemination had been excluded.
Thus the outcome figures derived are in line with preceding
evaluations.
Although the outcome after recurrent miscarriages is
favourable concerning child birth, the risk of premature
delivery and perinatal foetal loss has been observed to be
elevated at the same time. In a large retrospective study, the
rate of premature delivery was 8.1 %, of premature delivery
2.2 %, and of perinatal death 1.2 % after recurrent miscar-
riages and thus found to be significantly higher than in a
population who had 0-2 miscarriages. Our figures even
exceed these numbers which may be explained by the fact
that we did not exclude multiple gestation. Moreover, the
rate of assisted conception was higher in our cohort (12 of
174, 6.9 vs. 4.2 %) [39]. The figures underline that pregnant
women with a history of recurrent miscarriages should be
offered special obstetric care. Those who develop subfer-
tility apparently are at higher risk than those who conceive
within 6 months after the last miscarriage, irrespective of
infertility treatment [40].
In summary, the outcome within 24 months correlates
well with basic information derived from the past obstetric
history. A preliminary prognostic score could be developed
which can help counselling couples individually after a
history of primary first trimester recurrent miscarriages
(Table 3). There are other factors like andrological infer-
tility, tubal and uterine anomalies, body mass index, and
lifestyle which may additionally contribute. Individual
fertility factors will possibly remain difficult to recognise
in couples conceiving spontaneously, unless further non-
invasive markers of embryonic development can be
established. In many cases, counselling and emotional
support may be the most important element of therapy.
Finally, it seems adequate to replace the idea of treatment
by measures for preventing a third miscarriage. Main
diagnostic and therapeutic options could aim at maintain-
ing fertility as best as possible including both partners.
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